Abstract:Despite of great advances of phospholipids and liposomes in clinical therapy, very limited success has been achieved in the preparation of smart phospholipids and controlled-release liposomes for in vivo drug delivery and clinical trials. Here we report a supramolecular approach to synthesize novel supramolecularly engineered phospholipids based on complementary hydrogen bonding of nucleosides, which greatly reduces the need of tedious chemical synthesis, including reducing the strict requirements for multistep chemical reactions, and the purification of the intermediates and the amount of waste generated relative more traditional approaches. These upgraded phospholipids self-assemble into liposome-like bilayer structures in aqueous solution, exhibiting fast stimuli-responsive ability due to the hydrogen bonding connection. In vitro and in vivo evaluations show the resulted supramolecular liposomes from nucleoside phospholipids could effectively transport drug into tumor tissue, rapidly enter tumor cells, and controllably release their payload in response to an intracellular acidic environment, thus resulting in a much higher antitumor activity than conventional liposomes. The present supramolecularly engineered phospholipids represent an important evolution in comparison to conventional covalent-bonded phospholipid systems.

Correction: Supramolecularly Engineered Phospholipids Constructed by Nucleobase Molecular Recognition: Upgraded Generation of Phospholipids for Drug Delivery

Correction: Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As a Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): a Physico-Chemical Study

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Supramolecularly Engineered Phospholipids Constructed by Nucleobase Molecular Recognition: Upgraded Generation of Phospholipids for Drug Delivery.

Correction: Supramolecular Metallacycles with a ‘pseudo Double-Paracyclophane’ Structure Based on Flexible Π-Conjugated Linkers

Correction: Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery

Correction: Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Correction: Enhanced DNA release from disulfide-containing layered nanocomplexes by heparin-electrostatic competition

Correction: Using single molecule force spectroscopy to facilitate a rational design of Ca2+-responsive β-roll peptide-based hydrogels

Correction and removal of expression of concern: Natural steroid-based cationic copolymers cholesterol/diosgenin- r-PDMAEMAs and their pDNA nanoplexes: impact of steroid structures and hydrophobic/hydrophilic ratios on pDNA delivery

Author Correction to ‘Amino-Functionalized Poloxamer 407 with Both Mucoadhesive and Thermosensitive Properties: Preparation, Characterization and Application in Vaginal Drug Delivery System’ [acta Pharm Sin B 7 (2017) 593–602]

Correction: Synthesis of heteroleptic phosphine–copper( i ) complexes: fluorescence sensing and catalytic properties

Correction: Geng et al. Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L. Biomolecules 2020, 10, 217

Correction: Multiple pH responsive zwitterionic micelles for stealth delivery of anticancer drugs

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Erratum to: Multifunctional peptide conjugated amphiphilic cationic copolymer for enhancing ECs targeting, penetrating and nuclear accumulation

Correction: Encapsulation of a photosensitizer into cell membrane capsules for photodynamic therapy

Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents